NO894811L - Vandig doxorubicinloesning. - Google Patents

Vandig doxorubicinloesning.

Info

Publication number
NO894811L
NO894811L NO89894811A NO894811A NO894811L NO 894811 L NO894811 L NO 894811L NO 89894811 A NO89894811 A NO 89894811A NO 894811 A NO894811 A NO 894811A NO 894811 L NO894811 L NO 894811L
Authority
NO
Norway
Prior art keywords
solution
doxorubic
doxorubicin
physiologically acceptable
solutions
Prior art date
Application number
NO89894811A
Other languages
English (en)
Norwegian (no)
Other versions
NO894811D0 (no
Inventor
Murray A Kaplan
Robert K Perrone
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO894811D0 publication Critical patent/NO894811D0/no
Publication of NO894811L publication Critical patent/NO894811L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
NO89894811A 1988-12-05 1989-12-01 Vandig doxorubicinloesning. NO894811L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (2)

Publication Number Publication Date
NO894811D0 NO894811D0 (no) 1989-12-01
NO894811L true NO894811L (no) 1990-06-06

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89894811A NO894811L (no) 1988-12-05 1989-12-01 Vandig doxorubicinloesning.

Country Status (20)

Country Link
EP (1) EP0372888B1 (hu)
JP (1) JPH02200637A (hu)
KR (1) KR920001460B1 (hu)
AT (1) ATE78402T1 (hu)
AU (1) AU612916B2 (hu)
DD (1) DD295990A5 (hu)
DE (1) DE68902223T2 (hu)
DK (1) DK609889A (hu)
ES (1) ES2044148T3 (hu)
FI (1) FI895733A0 (hu)
GR (1) GR3005391T3 (hu)
HU (1) HU204704B (hu)
IE (1) IE893867L (hu)
IL (1) IL92541A0 (hu)
NO (1) NO894811L (hu)
NZ (1) NZ231602A (hu)
OA (1) OA09898A (hu)
PT (1) PT92483B (hu)
YU (1) YU226189A (hu)
ZA (1) ZA899248B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
EP3417864A4 (en) * 2016-02-16 2019-08-21 General Incorporated Association Pharma Valley Project Supporting Organisation IMMUNOSUPPRESSION TENDERING AGENT AND USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
ES2044148T3 (es) 1994-01-01
DE68902223T2 (de) 1993-01-14
DD295990A5 (de) 1991-11-21
DK609889A (da) 1990-06-06
IE893867L (en) 1990-06-05
AU4591589A (en) 1990-06-07
KR900009081A (ko) 1990-07-02
IL92541A0 (en) 1990-08-31
EP0372888A1 (en) 1990-06-13
YU226189A (en) 1991-02-28
HUT52961A (en) 1990-09-28
FI895733A0 (fi) 1989-11-30
PT92483B (pt) 1995-08-09
DE68902223D1 (de) 1992-08-27
JPH02200637A (ja) 1990-08-08
ZA899248B (en) 1990-08-29
HU896426D0 (en) 1990-02-28
NZ231602A (en) 1991-12-23
ATE78402T1 (de) 1992-08-15
DK609889D0 (da) 1989-12-04
HU204704B (en) 1992-02-28
AU612916B2 (en) 1991-07-18
GR3005391T3 (hu) 1993-05-24
KR920001460B1 (ko) 1992-02-14
EP0372888B1 (en) 1992-07-22
OA09898A (fr) 1994-09-15
NO894811D0 (no) 1989-12-01
PT92483A (pt) 1990-06-29

Similar Documents

Publication Publication Date Title
SE8402551L (sv) Cinnamoylmoranolin-derivat
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
AU653371B2 (en) Pharmaceutical compositions
ES2033379T3 (es) Soluciones acuosas de clorhidrato de doxorubicina.
SE9102604L (sv) Farmaceutiska kompositioner innehaallande furanderivat
NO894811L (no) Vandig doxorubicinloesning.
ATE93731T1 (de) Protein enthaltende waesserige loesungen.
DE68905577T2 (de) Doxorubicin-loesungen.
ES8705866A1 (es) Procedimiento de preparar sales fungicidas